Siegel notes a new study showing the one year abstinence rate with big pharma NRT is 1.6%. Yet, as he also notes in another recent commentary, formal tobacco Control guidelines provided to all physicians instruct that, "Numerous effective pharmacotherapies for smoking cessation now exist. Except in the presence of contraindications, these should be used with all patients attempting to quit smoking."
Conflicts of Interest with Big Pharma Influence Reporting of the Effectiveness of Smoking Cessation Drug Treatment
Expert Panel on Smoking Cessation Also Had Severe Conflicts of Interest with Big Pharma
or just keep following his awesome blog at: The Rest of the Story: Tobacco News Analysis and Commentary
Conflicts of Interest with Big Pharma Influence Reporting of the Effectiveness of Smoking Cessation Drug Treatment
Expert Panel on Smoking Cessation Also Had Severe Conflicts of Interest with Big Pharma
or just keep following his awesome blog at: The Rest of the Story: Tobacco News Analysis and Commentary